MIAMI–(BUSINESS WIRE)–OpenEvidence, the most widely-used AI platform by doctors in America, announced today that it closed a Series D round of funding, valuing the company at $12 billion. This makes OpenEvidence the most valuable Healthcare AI company in the world.
OpenEvidence is a specialized AI-powered medical search engine that serves as a “brain extender” for clinicians by providing real-time, citation-linked answers synthesized exclusively from the world’s most trusted, peer-reviewed medical literature.
“If a doctor tried to stay current by reading only the new evidence in the top 10 medical journals and only the most recent changes to their specialty guidelines, it would take nine hours of their day, each day,” said Daniel Nadler, founder and CEO of OpenEvidence. “Without a technology like OpenEvidence, doctors may miss critical new findings or guidelines simply because they lack the time to find them. Doctors want to provide the best care to patients. OpenEvidence is the tool that safely allows them to do that. Our mission is to help doctors save lives and improve patient care.”